High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-15

Study Completion Date

2026-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neurological Outcomes of Primary Intracerebral Haemorrhage

NCT03995940

Intracranial Hemorrhage, Hypertensive

UNKNOWN

Perfusion Imaging Score to Predict Delayed Cerebral Ischemia

NCT07030985

Aneurysmal Subarachnoid Hemorrhage Cerebral Ischemia

NOT_YET_RECRUITING NA

Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage

NCT01773200

Aneurysmal Subarachnoid Hemorrhage

UNKNOWN

Noncontrast CT-Based Deep Learning for Predicting Hematoma Expansion Risk in Patients with Spontaneous Intracerebral Hemorrhage

NCT06602115

Spontaneous Intracerebral Hemorrhage Hematoma Expansion

NOT_YET_RECRUITING

The Spot Sign for Predicting and Treating ICH Growth Study

NCT00810888

Intracerebral Hemorrhage

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracerebral Hemorrhage Cerebral Hemorrhage Stroke Brain Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intracerebral Hemorrhage Without Spot Sign or Secondary Morphological Marker

No interventions assigned to this group

Spot Sign Only

No interventions assigned to this group

Spot Sign With a Secondary Morphological Marker

No interventions assigned to this group

Single Secondary Morphological Marker Without Spot Sign

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan.
* Follow-up CT scan performed within 24 to 48 hours.

* Absence of initial contrast-enhanced CT or follow-up CT.
* Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH).